NEO-STIM Trademark

Trademark Overview

On Thursday, June 14, 2018, a trademark application was filed for NEO-STIM with the United States Patent and Trademark Office. The USPTO has given the NEO-STIM trademark a serial number of 88000880. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 26, 2022. This trademark is owned by Neon Therapeutics, Inc.. The NEO-STIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations; medical assays for testing of body fluids
neo-stim

General Information

Serial Number88000880
Word MarkNEO-STIM
Filing DateThursday, June 14, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 26, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 25, 2019

Trademark Statements

Goods and ServicesPharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations; medical assays for testing of body fluids

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 20, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBioNTech US Inc.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameNeon Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameNeon Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, September 26, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 26, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, January 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 27, 2022SOU EXTENSION 5 GRANTED
Tuesday, January 25, 2022SOU EXTENSION 5 FILED
Tuesday, January 25, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 17, 2021SOU EXTENSION 4 GRANTED
Tuesday, August 17, 2021SOU EXTENSION 4 FILED
Tuesday, August 17, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 14, 2021SOU EXTENSION 3 GRANTED
Monday, February 22, 2021SOU EXTENSION 3 FILED
Tuesday, March 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 22, 2021SOU TEAS EXTENSION RECEIVED
Friday, August 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 19, 2020SOU EXTENSION 2 GRANTED
Wednesday, August 19, 2020SOU EXTENSION 2 FILED
Wednesday, August 19, 2020SOU TEAS EXTENSION RECEIVED
Friday, May 1, 2020ASSIGNED TO EXAMINER
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 19, 2020SOU EXTENSION 1 GRANTED
Wednesday, February 19, 2020SOU EXTENSION 1 FILED
Wednesday, February 19, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, February 19, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 19, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 19, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 20, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 25, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 25, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 5, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 23, 2019ASSIGNED TO LIE
Thursday, May 9, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 9, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, May 9, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 9, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, May 9, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, May 6, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, May 6, 2019FINAL REFUSAL E-MAILED
Monday, May 6, 2019FINAL REFUSAL WRITTEN
Wednesday, April 10, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 9, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 10, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 10, 2018NON-FINAL ACTION E-MAILED
Wednesday, October 10, 2018NON-FINAL ACTION WRITTEN
Monday, October 1, 2018ASSIGNED TO EXAMINER
Wednesday, June 20, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 18, 2018NEW APPLICATION ENTERED

Related Keywords

stim cancer oncological treatment conditions preparations prevention pharmaceutical products namely assays